Read + Share
Yamamura A, Nayeem MJ, Sato M. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of
pulmonary arterial hypertension. Biochem Biophys Res Commun 2020 Nov 5. pii: S0006-291X(20)32035.
PMID: 33160621
|
 |
|
Yamamura A, Nayeem MJ, Sato M. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of
pulmonary arterial hypertension. Biochem Biophys Res Commun 2020 Nov 5. pii: S0006-291X(20)32035.
PMID: 33160621
|
|
|
|